Tower Research Capital LLC TRC Takes $411,000 Position in Everus (NYSE:ECG)

Tower Research Capital LLC TRC bought a new position in Everus (NYSE:ECG - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 6,248 shares of the company's stock, valued at approximately $411,000.

Several other large investors have also added to or reduced their stakes in ECG. First Trust Advisors LP acquired a new position in shares of Everus in the 4th quarter valued at $1,416,000. Dimensional Fund Advisors LP acquired a new position in shares of Everus in the fourth quarter worth about $120,578,000. Alpha Wave Global LP purchased a new stake in shares of Everus during the 4th quarter worth about $9,091,000. MSH Capital Advisors LLC acquired a new stake in shares of Everus during the 4th quarter valued at about $270,000. Finally, Marshall Wace LLP purchased a new position in shares of Everus in the 4th quarter valued at about $7,068,000.

Insider Activity

In related news, Director Rocca Michael Della acquired 1,050 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were purchased at an average cost of $47.56 per share, for a total transaction of $49,938.00. Following the acquisition, the director now owns 2,027 shares in the company, valued at $96,404.12. The trade was a 107.47 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Maximillian J. Marcy bought 1,300 shares of the stock in a transaction that occurred on Tuesday, February 25th. The shares were purchased at an average price of $38.99 per share, with a total value of $50,687.00. Following the completion of the acquisition, the chief financial officer now directly owns 5,508 shares in the company, valued at $214,756.92. This trade represents a 30.89 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 3,750 shares of company stock valued at $153,853 in the last 90 days. Company insiders own 0.21% of the company's stock.

Everus Stock Performance

Shares of NYSE:ECG traded up $0.10 during trading on Tuesday, reaching $45.50. The stock had a trading volume of 45,208 shares, compared to its average volume of 718,162. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.58 and a quick ratio of 1.50. Everus has a 1-year low of $31.38 and a 1-year high of $77.93. The stock has a fifty day moving average of $38.76.

Everus (NYSE:ECG - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 EPS for the quarter, missing analysts' consensus estimates of $0.73 by ($0.06). As a group, equities research analysts expect that Everus will post 2.49 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on ECG. Stifel Nicolaus reduced their target price on Everus from $67.00 to $55.00 and set a "buy" rating for the company in a research note on Wednesday, April 9th. Oppenheimer increased their price objective on shares of Everus from $70.00 to $80.00 and gave the company an "outperform" rating in a report on Tuesday, January 7th.

About Everus

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.